西班牙检验与血液学会MALDI-TOF质谱检测单克隆丙种球蛋白病共识(第三部分)
该共识由西班牙检验医学学会(SEMEDLAB)与西班牙血液学与血液治疗学会(SEHH)联合制定,针对MALDI-TOF质谱法检测和监测单克隆丙种球蛋白病(MGs)患者M蛋白给出临床与分析推荐。质谱法为无创、高灵敏的替代方法,有助于更精确评估治疗反应与残留病,尤其适用于疑似完全缓解、不宜骨髓检查或接受单克隆抗体治疗的患者。
要点
- 质谱法可无创、高灵敏地检出和定量M蛋白。
- 疑似完全缓解或不宜骨髓检查者可用质谱评估残留病。
- 单克隆抗体治疗可能干扰常规检测,质谱是替代选择。
核心结论
- MALDI-TOF质谱可用于MGs患者M蛋白的检测与监测,推荐覆盖诊断、随访和报告环节。
研究设计与样本
- 西班牙检验医学学会(SEMEDLAB)与西班牙血液学与血液治疗学会(SEHH)联合制定的共识指南。
主要发现
- 质谱法为无创、高灵敏的替代方法,可更精确评估治疗反应与残留病。
临床怎么用
- 在诊断、随访及报告中规范应用质谱法,遵循标准化实施与判读标准以支持临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monoclonal gammopathies (MGs) represent a diverse group of plasma cell disorders that range from asymptomatic premalignant conditions to aggressive malignancies such as multiple myeloma (MM). Mass spectrometry (MS) based serum analysis offers a non-invasive, highly sensitive alternative to conventional techniques for identifying and quantifying M-proteins. It enables more precise assessment of treatment response and residual disease, particularly in patients with suspected complete response (CR), those not eligible for bone marrow procedures, or those treated with monoclonal antibodies that may interfere with standard assays. This guideline document, endorsed by the Spanish Society of Laboratory Medicine (SEMEDLAB) and the Spanish Society of Hematology (SEHH), provides comprehensive recommendations for the clinical and analytical application of MS in the detection and monitoring of M-proteins in patients with MGs. The document outlines optimal use of MS at diagnosis, during follow-up, and in reporting practices, with a focus on standardized implementation, interpretative criteria, and clinical decision-making support.
引用
- Agulló C, Puig N, Varo N, et al. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry. Clin Chem Lab Med. 2025. PMID: 41182012. doi:10.1515/cclm-2025-1056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。